Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 04, 2018 07:05 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences to Present at the J.P. Morgan Healthcare Conference

INDIANAPOLIS, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...
December 18, 2017 16:05 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Appoints Sue Mahony, PhD to Board of Directors

INDIANAPOLIS, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...
December 08, 2017 17:53 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

INDIANAPOLIS, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...
November 08, 2017 07:00 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences to Present at the Jefferies London Healthcare Conference

INDIANAPOLIS, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...
November 02, 2017 00:40 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Announces Pricing of $60 Million Offering of Common Stock

INDIANAPOLIS, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB) (“Assembly” or the “Company”), a clinical-stage biotechnology company advancing a new class of oral...
November 01, 2017 16:01 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Announces Proposed Underwritten Offering of Common Stock

INDIANAPOLIS, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB) (“Assembly” or the “Company”), a clinical-stage biotechnology company advancing a new class of oral...
October 05, 2017 07:00 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

INDIANAPOLIS, Oct. 05, 2017 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...
October 02, 2017 07:00 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Announces 2017 AASLD Presentations

INDIANAPOLIS, Oct. 02, 2017 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...
September 25, 2017 07:00 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Selects Next-Generation CpAM Candidate for Advancement into Clinical Development

INDIANAPOLIS, Sept. 25, 2017 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...
August 31, 2017 07:00 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Announces September Conference Participation

INDIANAPOLIS, Aug. 31, 2017 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...